Marlborough’s Cytiva, the rebranded GE Healthcare Life Sciences, has been named as a founding member of a forthcoming 40,000 square-foot manufacturing and innovation center at the The Arsenal on the Charles in Watertown, according to a Thursday press release from Harvard University.
Once ready, the facility will be home to the Massachusetts Center for Advanced Biological Innovation and Manufacturing, or CABIM, which was founded in 2019. The site is expected to open in early 2022.
Cytiva sits on CABIM’s board of directors, which also includes Harvard University, Massachusetts Institute of Technology in Cambridge, FUJIFILM Diosynth Biotechnologies, which maintains domestic offices in North Carolina and Texas, and Alexandria Real Estate Equities, Inc. of California, which owns and operates The Arsenal. The initiative recently completed a $76 million fundraising effort.